Last updated on November 2017

A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (spinosad) for the Treatment of Scabies


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Dermatology | ATOPIC DERMATITIS | Family Practice | Healthy People 2010 | Seborrheic dermatitis
  • Age: Between 4 - 100 Years
  • Gender: Male or Female

-At least one household member must have active scabies infestation.

-Household members must be 6 or fever and all members must be willing to attend clinic visits.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.